Future Directions in Dermatology Quality of Life Measures

Dermatologic Clinics

Volumn 30, Issue 2, 2012, Pages 343-347

  DeLong, Laura K ^a,b   Chen, Suephy C ^b,c  

^a EMORY CLINIC   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical significance; Dermatology health status; Guidelines; Quality of life

Indexed keywords

DERMATOLOGY; DERMATOLOGY LIFE QUALITY INDEX; EVIDENCE BASED MEDICINE; HEALTH STATUS; HUMAN; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUALITY OF LIFE INDEX; QUESTIONNAIRE; REVIEW; SCORING SYSTEM; SKIN DISEASE; SOCIAL PSYCHOLOGY; WELLBEING;

DERMATOLOGY; FORECASTING; HEALTH STATUS; HUMANS; QUALITY OF LIFE; QUESTIONNAIRES; SKIN DISEASES; TREATMENT OUTCOME;

EID: 84863041004     PISSN: 07338635     EISSN: 15580520     Source Type: Journal    
DOI: 10.1016/j.det.2011.11.005     Document Type: Review

References (17)

1. Kaplan R.M. The significance of quality of life in health care. Qual Life Res 2003, 12(Suppl 1):3-16. [review].
2. Chen S.C. Dermatology quality of life instruments: sorting out the quagmire. JInvest Dermatol 2007, 127(12):2695-2696.
3. Both H., Essink-Bot M.L., Busschbach J., et al. Critical review of generic and dermatology-specific health-related quality of life instruments. JInvest Dermatol 2007, 127(12):2726-2739. [review].
4. Scientific Advisory Committee of the Medical Outcomes Trust Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002, 11(3):193-205. [review].
5. Testa M.A., Simonson D.C. Assessment of quality-of-life outcomes. NEngl J Med 1996, 334(13):835-840.
6. Charman C., Chambers C., Williams H. Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring?. JInvest Dermatol 2003, 120(6):932-941.
7. Hongbo Y., Thomas C.L., Harrison M.A., et al. Translating the science of quality of life into practice: what do dermatology life quality index scores mean?. JInvest Dermatol 2005, 125(4):659-664.
8. Wyrwich K.W., Nienaber N.A., Tierney W.M., et al. Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care 1999, 37(5):469-478.
9. Norman G.R., Sloan J.A., Wyrwich K.W. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003, 41:582-592.
10. Guyatt G., Schunemann H. How can quality of life researchers make their work more useful to health workers and their patients?. Qual Life Res 2007, 16(7):1097-1105.
11. Ferguson R.J., Robinson A.B., Splaine M. Use of the reliable change index to evaluate clinical significance in SF-36 outcomes. Qual Life Res 2002, 11(6):509-516.
12. Wyrwich K.W., Tierney W.M., Wolinsky F.D. Further evidence supporting an SEM-based criterion for identifying meaningful intraindividual changes in health-related quality of life. JClin Epidemiol 1999, 52:861-873.
13. Hays R.D., Farivar S.S., Liu H. Approaches and recommendations for estimating minimally important differences for health-related quality of life measures. COPD 2005, 2:63-67.
14. Shikiar R., Harding G., Leahy M., et al. Minimal important difference (MID) of the Dermatology Life Quality Index (DLQI): results from patients with chronic idiopathic urticaria. Health Qual Life Outcomes 2005, 3:36.
15. Shikiar R., Willian M.K., Okun M.M., et al. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study. Health Qual Life Outcomes 2006, 4:71.
16. Swigris J.J., Stewart A.L., Gould M.K., et al. Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Health Qual Life Outcomes 2005, 3:61.
17. Outcomes research. Fact sheet. Rockville (MD): Agency for Healthcare Research and Quality; AHRQ Publication No. 00-P011, March 2000. Available at: Accessed September 15, 2011. http://www.ahrq.gov/clinic/outfact.htm.